Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1958 1
1960 1
1965 3
1966 2
1969 2
1970 1
1971 2
1973 2
1974 2
1975 2
1976 1
1983 2
1985 5
1987 5
1988 3
1989 3
1990 3
1991 1
1992 4
1993 3
1994 2
1995 7
1996 4
1997 6
1998 7
1999 6
2000 7
2001 9
2002 9
2003 15
2004 14
2005 11
2006 10
2007 16
2008 21
2009 20
2010 16
2011 21
2012 17
2013 27
2014 32
2015 31
2016 34
2017 33
2018 33
2019 29
2020 40
2021 42
2022 23
Text availability
Article attribute
Article type
Publication date

Search Results

536 results
Results by year
Filters applied: . Clear all
Page 1
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
ACTIV-3/TICO LY-CoV555 Study Group, Lundgren JD, Grund B, Barkauskas CE, Holland TL, Gottlieb RL, Sandkovsky U, Brown SM, Knowlton KU, Self WH, Files DC, Jain MK, Benfield T, Bowdish ME, Leshnower BG, Baker JV, Jensen JU, Gardner EM, Ginde AA, Harris ES, Johansen IS, Markowitz N, Matthay MA, Østergaard L, Chang CC, Davey VJ, Goodman A, Higgs ES, Murray DD, Murray TA, Paredes R, Parmar MKB, Phillips AN, Reilly C, Sharma S, Dewar RL, Teitelbaum M, Wentworth D, Cao H, Klekotka P, Babiker AG, Gelijns AC, Kan VL, Polizzotto MN, Thompson BT, Lane HC, Neaton JD. ACTIV-3/TICO LY-CoV555 Study Group, et al. Among authors: paredes r. N Engl J Med. 2021 Mar 11;384(10):905-914. doi: 10.1056/NEJMoa2033130. Epub 2020 Dec 22. N Engl J Med. 2021. PMID: 33356051 Free PMC article. Clinical Trial.
Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients.
Gottlieb RL, Vaca CE, Paredes R, Mera J, Webb BJ, Perez G, Oguchi G, Ryan P, Nielsen BU, Brown M, Hidalgo A, Sachdeva Y, Mittal S, Osiyemi O, Skarbinski J, Juneja K, Hyland RH, Osinusi A, Chen S, Camus G, Abdelghany M, Davies S, Behenna-Renton N, Duff F, Marty FM, Katz MJ, Ginde AA, Brown SM, Schiffer JT, Hill JA; GS-US-540-9012 (PINETREE) Investigators. Gottlieb RL, et al. Among authors: paredes r. N Engl J Med. 2022 Jan 27;386(4):305-315. doi: 10.1056/NEJMoa2116846. Epub 2021 Dec 22. N Engl J Med. 2022. PMID: 34937145 Free PMC article. Clinical Trial.
Chemical calcium indicators.
Paredes RM, Etzler JC, Watts LT, Zheng W, Lechleiter JD. Paredes RM, et al. Methods. 2008 Nov;46(3):143-51. doi: 10.1016/j.ymeth.2008.09.025. Epub 2008 Oct 16. Methods. 2008. PMID: 18929663 Free PMC article. Review.
2019 update of the drug resistance mutations in HIV-1.
Wensing AM, Calvez V, Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R, Shafer RW, Richman DD. Wensing AM, et al. Among authors: paredes r. Top Antivir Med. 2019 Sep;27(3):111-121. Top Antivir Med. 2019. PMID: 31634862 Free PMC article.
Neurogenesis and sexual behavior.
Bedos M, Portillo W, Paredes RG. Bedos M, et al. Among authors: paredes rg. Front Neuroendocrinol. 2018 Oct;51:68-79. doi: 10.1016/j.yfrne.2018.02.004. Epub 2018 Feb 10. Front Neuroendocrinol. 2018. PMID: 29438737 Review.
Hormones and the Coolidge effect.
Ventura-Aquino E, Fernández-Guasti A, Paredes RG. Ventura-Aquino E, et al. Among authors: paredes rg. Mol Cell Endocrinol. 2018 May 15;467:42-48. doi: 10.1016/j.mce.2017.09.010. Epub 2017 Sep 12. Mol Cell Endocrinol. 2018. PMID: 28912031 Review.
Opioids and sexual reward.
Paredes RG. Paredes RG. Pharmacol Biochem Behav. 2014 Jun;121:124-31. doi: 10.1016/j.pbb.2013.11.004. Epub 2013 Nov 15. Pharmacol Biochem Behav. 2014. PMID: 24239788 Review.
Deep sequencing for HIV-1 clinical management.
Casadellà M, Paredes R. Casadellà M, et al. Among authors: paredes r. Virus Res. 2017 Jul 15;239:69-81. doi: 10.1016/j.virusres.2016.10.019. Epub 2016 Nov 3. Virus Res. 2017. PMID: 27818211 Review.
Hormones and sexual reward.
Paredes RG. Paredes RG. Vitam Horm. 2010;82:241-62. doi: 10.1016/S0083-6729(10)82013-8. Vitam Horm. 2010. PMID: 20472142 Review.
536 results